Error message

Notice: Undefined offset: 1 in counter_get_browser() (line 70 of /home/mitochondrium/sites/mitochondrium.med.unideb.hu/public_html/sites/all/modules/counter/counter.lib.inc).

Publications:

publication

Publications

2014

El-Hamoly T, Hegedűs Cs, Lakatos P, Kovács K, Bai P, M El-Ghazaly, E El-Denshary, Szabó É, Virág L Activation of poly(ADP-ribose) polymerase-1 delays wound healing by regulating keratinocyte migration and production of inflammatory mediators. Molecular Medicine

IF: 4.469

2013

Szántó M, Brunyánszki A, Márton J, Vámosi Gy, Nagy L, Kiss B, Virág L, Gergely P, Bai P Deletion of PARP-2 induces hepatic cholesterol accumulation and decrease in HDL levels. Biochimica and Biophysica Acta – Molecular Basis of Disease. in press

IF: 4.91

Csóka B, Koscsó B, Töro G, Kókai E, Virág L, Németh ZH, Pacher P, Bai P, Haskó G. (2013) A2B adenosine receptors prevent insulin resistance by inhibiting adipose tissue inflammation via maintaining alternative macrophage activation. Diabetes. DOI: 102337/db13-0573

IF: 7.895

 

Tóth A, Czikora Á, Pásztor ET, Dienes B, Bai P, Csernoch L, Rutkai I, Csató V, Mányiné IS, Pórszász R, Édes I, Papp Z, Boczán J (2013) Vanilloid receptor-1 (TRPV1) expression and function in the vasculature of the rat. JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY in press

IF: 2.255

 

Xu S, Bai P, Little P, Liu P (2013) Poly(ADP-ribose) Polymerase-1 (PARP1) in Atherosclerosis: From Molecular Mechanisms to Therapeutic Potential. Medicinal Research Reviews DOI: 10.1002/med.21300.

IF: 9.583

 

Nagy L, Docsa T, Brunyánszki A, Szántó M, Hegedűs C, Márton J, Kónya B, Virág L, 
Gergely P, Somsák L, Bai P.  Glycogen phosphorylase inhibitor 
N-(3,5-dimethyl-benzoyl)-N’-(β-D-glucopyranosyl)carbamide induces hepatic catabolism. 
PLOS One 8(7):e69420.
IF: 4.092

 

Hegedűs C, Lakatos P, Kiss-Szikszai A, Patonay T, Gergely S, Gregus A, Bai P, Haskó G, Szabó E, Virág L. (2013) Cytoprotective dibenzoylmethane derivatives protect cells from oxidative stress-induced necrotic cell death. Pharmacol Res. 72C:25-34.

IF: 4.436

Cantó C, Sauve AA, Bai P (2013) Crosstalk between poly(ADP-ribose) polymerase and sirtuin enzymes. Molecular Aspects of Medicine DOI: 10.1016/j.mam.2013.01.004

IF: 9.97

Lakatos P, Szabó É, Hegedus Cs, Haskó Gy, Gergely P, Bai P, Virág L (2013) 3-aminobenzamide protects primary human keratinocytes from UV-induced cell death by a poly(ADP-ribosyl)ation independent mechanism. Biochimica et Biophysica Acta - Molecular Cell Research 1833:743-51.

IF: 5.538

 

2012

Bai P, Virág L (2012) Role of poly(ADP-ribose) polymerases in the regulation of inflammatory processes. FEBS Letters 586(21):3771-7.

IF: 3.33

Kovács K, Erdélyi K, Hegedus Cs, Lakatos P, Regdon Zs, Bai P, Haskó Gy, Szabó É, Virág L (2012) Poly(ADP-ribosyl)ation is a survival mechanism in cigarette smoke-induced and hydrogen peroxide-mediated cell death. Free Racial Biology and Medicine 53(9):1680-8.

IF: 5.423

Robaszkiewicz A, Erdélyi K, Kovács K, Kovács I, Bai P, Rajnavölgyi É, Virág L (2012) Hydrogen peroxide-induced poly(ADP-ribosyl)ation regulates osteogenic differentiation-associated cell death. Free Racial Biology and Medicine 53(8):1552-64.

IF: 5.423

Bai P, Cantó C. (2012) The role of PARP-1 and PARP-2 enzymes in metabolic regulation and disease. Cell Metab.16(5) 290-295.

IF: 13.668

Szántó M, Brunyánszki A, Kiss B, Nagy L, Gergely P, Virág L, Bai P (2012) Poly(ADP-ribose) polymerase-2: emerging transcriptional roles of a DNA repair protein. Cellular and Molecualr Life Sciences 69(24):4079-92

IF: 6.57

Géhl Z*, Bai P*, Bodnár E, Emri G, Remenyik É, Németh J, Gergely P, Virág L, Szabó É (2012) Poly(ADP-ribose) in the skin and in malignant melanomas. Histology and histopathology 27(5):651-9. *joint first authors

IF:2.48

 

2011

Szántó M, Rutkai I, Hegedűs Cs, Czikora Á, Rózsahegyi M, Kiss B, Virág L, Gergely P, Tóth A, Bai P (2011) Poly(ADP-ribose) polymerase-2 depletion reduces doxorubicin-induced damage through SIRT1 induction. Cardiovascular Research. 92:(3) 430-438.

IF: 6.064

Bai P, Canto C, Brunyánszki A, Huber A, Szántó M, Cen Y, Yamamoto H, Houten SM, Kiss B, Oudart H, Gergely P, Schreiber V, Sauve AA, Menissier-de Murcia J, Auwerx J (2011) The absence of PARP-2 promotes SIRT1 expression and enhances whole body energy expenditure. Cell Metab. 13(4):450-60.

IF: 13.668

Bai P, Canto C, Oudart H, Brunyánszki A, Cen Y, Thomas C, Yamamoto Y, Huber A, Kiss B, Houtkooper RH, Schoonjans K, Schreiber V, Sauve AA, Menissier-de Murcia J, Auwerx J  (2011) PARP-1 inhibition increases mitochondrial metabolism through SIRT1 activation. Cell Metab. 13(4):461-8.

IF: 13.668

 

2010

Brunyánszki A, Hegedűs Cs, Szántó M, Erdélyi K, Kovács K, Schreiber V, Gergely Sz, Kiss B, Szabó É, Virág L, Bai P (2010) Genetic ablation of PARP-1 protects against oxazolone-induced contact hypersensitivity by modulating oxidative stress. J Invest Dermatol 130, 2629–2637.

IF: 6.27


2009
Erdelyi K, Bai P, Kovacs I, Szabo E, Mocsar G, Kakuk A, Szabo C, Gergely P, Virag L (2009) Dual role of poly(ADP-ribose) glycohydrolase 
in the regulation of cell death in oxidatively stressed A549 cells. FASEB J. 23(10):3553-3563. 
  IF: 6.401

Kolozsvari B, Szijgyarto Z, Bai P, Gergely P, Bako E. (2009) Role of calcineurin (PP2B) in thrombin-mediated endothelial cell contraction. Cytometry part A. 75(5), 405-411.

IF: 3.032

Bai P, Hegedűs Cs, Szabó E, Gyüre L, Bakondi E, Brunyánszki A, Gergely Sz, Szabó C, Virág L. (2009) Poly(ADP-ribose) polymerase mediates inflammation in a mouse model of contact hypersensitivity. J Invest Dermatol. 129, 234–238.

IF: 5.543

 

2007

Bai P, Houten SM, Huber A, Schreiber V, Watanabe M, Kiss B, de Murcia G, Auwerx J, Ménissier-de Murcia J. (2007) PARP-2 controls adipocyte differentiation and adipose tissue function through the regulation of the activity of the RXR/PPARg heterodimer. J Biol Chem. 282, 37738-37746.

IF: 5.581

Bai P, Hegedűs Cs, Erdélyi K, Szabó E, Bakondi E, Gergely Sz, Szabó Cs, Virág L (2007) Protein tyrosine nitration and poly(ADP-ribose) polymerase activation in N-methyl-N-nitro-N-nitrosoguanidine-treated thymocytes: implication for cytotoxicity. Toxicol Lett. 170(3), 203-213.

IF.: 2.826

 

2005

Erdelyi K, Kiss A, Bakondi E, Bai P, Szabo C, Gergely P, Erdodi F, Virag L. (2005) Gallotannin inhibits the expression of chemokines and inflammatory cytokines in A549 cells. Molecular Pharmacology 68(3), 895-904.

IF.: 4.612

 

2004

Huber A, Bai P, de Murcia G, Ménissier-de Murcia J. PARP-1, PARP-2 and ATM in the DNA damage response : functional synergy in mouse development? (2004) DNA repair 3, 1103 -1108.

IF.: 3.92

Mabley JG, Pacher P, Bai P, Wallace R, Goonesekera S, Virag L, Southan GJ, Szabo C. (2004) Suppression of intestinal polyposis in Apcmin/+ mice by inhibition of inducible nitric oxide synthase, inhibition of poly-(ADP-ribose) synthetase or neutralization of peroxynitrite. Mutat. Res. 548(1-2), 107-116.

IF.: 3.73

Virag L, Bai P, Bak I., Pacher P, Mabley JG, Liaudet L, Bakondi E, Gergely P, Kollai M, Szabo C. (2004) Effects of poly(ADP-ribose) polymerase inhibition on inflammatory cell migration in a murine model of asthma. Med Sci Monit. 10(3), BR77-83.

Bakondi E., Bai P, Erdelyi K, Szabo E, Gergely P, Hunyadi J, Szabo C, Virag L. (2004) Cytoprotective effect of gallotannin in oxidatively stressed HaCaT keratinocytes: the role of poly(ADP-ribose) metabolism. Exp. Derm. 13(3), 170-178.

IF.: 2.040

Bai P, Mabley JG, Liaudet L, Virag L, Szabo C, Pacher P. (2004) Matrix metalloproteinase activation is an early event in doxorubicin-induced cardiotoxicity. Oncol. Rep. 11(2), 501-505.

IF.: 1.356

 

2003

Bakondi E, Gonczi M, Szabo E, Bai P, Pacher P, Gergely P, Kovacs L, Hunyadi J, Szabo C,  Csernoch L, Virag L. (2003) Role of intracellular calcium mobilization and cell density-dependent signaling in oxidative stress-induced cytotoxicity in HaCaT keratinocytes. J. Invest. Dermatol. 121(1), 88-95.

IF.: 4.194

Pacher P, Liaudet L, Bai P, Mabley J, Kaminsky PM, Virag L, Deb A, Szabo E, Ungvari Z, Wolin MS, Szabo C. (2003) A potent peroxynitrite decomposition catalyst, FP15, protects against the development of doxorubicin-induced cardiac dysfunction. Circulation 107, 896-904.

IF.: 11.164

 

2002

Virag L, Szabo E, Bakondi E, Bai P, Gergely P, Hunyadi J, Szabo C. (2002) The nitric oxide – peroxynitrite - poly(ADP-ribose) polymerase pathway in the skin. Exp. Derm. 11(3), 189-202.

IF.:  2.303

Pacher P, Liaudet L, Bai P, Virag L, Mabley JG, Hasko G, Szabo C. (2002) The activation of poly(ADP-ribose) polymerase contributes to the development of doxorubicin-induced heart failure. J. Pharmacol. Exp.  Ther. 300, 862-867.

  IF.: 3.991

Bakondi E, Bai P, Szabo E, Hunyadi J, Gergely P, Szabo C, Virag L. (2002) Detection of poly(ADP-ribose) polymerase activation in oxidatively stressed cells and tissues by using biotinylated NAD substrate. J. Histochem. Cytochem. 50(1), 91-98.

IF.: 2.283

 

2001

Bai P, Bakondi E, Szabo E, Gergely P, Szabo C, Virag L. (2001) Partial protection by poly(ADP-ribose)polymerase inhibitors from nitroxyl-induced cytotoxicity in thymocytes. Free. Radical. Bio. Med. 31(12), 1616-1623.

IF.: 5.082

Szabo E, Virag L, Bakondi E, Gyure L, Hasko G, Bai P, Hunyadi J, Gergely P, Szabo C. (2001) Peroxynitrite-induced poly(ADP-ribose) polymerase activation in keratinocytes: implications for contact hypersensitivity. J. Invest. Dermatol. 117(1), 74-80.

  IF.: 4.645